Browsing by Author "Okwundu, C. I."

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns
    (John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration, 2017) Okwundu, C. I.; Uthman, O. A.; Suresh, G.; Smith, J.; Wiysonge, Charles S.; Bhutani, V. K.
    This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: - To determine the diagnostic accuracy of TcB as: i) a diagnostic test for hyperbilirubinaemia in newborns suspected to have hyperbilirubinaemia on visual inspection; ii) a diagnostic test for monitoring bilirubin levels in newborns receiving treatment (e.g. phototherapy) for hyperbilirubinaemia. - To determine whether the gestational age, postnatal age, body weight, race and site of TcB measurement have any influence on the accuracy of TcB measurement for hyperbilirubinaemia in newborns.
  • Thumbnail Image
    Item
    Transcutaneous screening for hyperbilirubinemia in neonates
    (Cochrane, 2014) Smith, J.; Uthman, O. A.; Okwundu, C. I.
    This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate to the effects of transcutaneous screening for hyperbilirubinemia to prevent the readmission of neonates for phototherapy.
  • Thumbnail Image
    Item
    Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults
    (Cochrane, 2014) Gbabe, O. F.; Okwundu, C. I.; Dedicoat, M.; Freeman, E. E.
    Background: Kaposi’s sarcoma remains the most common cancer in Sub-Saharan Africa and the second most common cancer in HIV-infected patients worldwide. Since the introduction of highly active antiretroviral therapy (HAART), there has been a decline in its incidence. However, Kaposi’s sarcoma continues to be diagnosed in HIV-infected patients. Objectives: To assess the added advantage of chemotherapy plusHAART compared toHAART alone; and the advantages of different chemotherapy regimens in HAART and HAART naive HIV infected adults with severe or progressive Kaposi’s sarcoma.
  • Thumbnail Image
    Item
    Zinc supplementation for the treatment ofmeasles in children (Review)
    (2014) Awotiwon, A. A.; Oduwole, O.; Sinha, A.; Okwundu, C. I.
    Background: Measles is an important cause of childhoodmorbidity andmortality globally, despite increasing vaccine coverage. Zinc plays a significant role in the maintenance of normal immunological functions, therefore supplements given to zinc-deficient children will increase the availability of zinc and could reduce measles-related morbidity and mortality. This is an update of a review first published in 2015. Objectives: To assess the effects of zinc supplementation in reducing morbidity and mortality in children with measles.